{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:12:07Z","timestamp":1785211927770,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.crad.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T03:16:48Z","timestamp":1488856608000},"page":"598-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?"],"prefix":"10.1016","volume":"72","author":[{"given":"A.F.","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tremblay St-Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abdolell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jamcollsurg.2006.12.032","article-title":"Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy","volume":"204","author":"Mullen","year":"2007","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.crad.2017.02.004_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jso.23671","article-title":"Preoperative assessment of postoperative liver function: the importance of residual liver volume","volume":"110","author":"Pulitano","year":"2014","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.crad.2017.02.004_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1478-3231.2008.01777.x","article-title":"Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment","volume":"28","author":"van den Broek","year":"2008","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.crad.2017.02.004_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00534-009-0228-x","article-title":"Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective","volume":"17","author":"Manizate","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"10.1016\/j.crad.2017.02.004_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests: a review","volume":"257","author":"Hoekstra","year":"2013","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.crad.2017.02.004_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1148\/radiol.13130210","article-title":"Liver failure after major liver resection: risk assessment by using preoperative gadoxetic acid-enhanced 3-T MR imaging","volume":"269","author":"Wibmer","year":"2013","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e318269d2ec","article-title":"Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes","volume":"257","author":"Wong","year":"2013","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.crad.2017.02.004_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1477-2574.2011.00329.x","article-title":"Predictors of peri-opertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease","volume":"13","author":"Greco","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.crad.2017.02.004_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2214\/AJR.13.12399","article-title":"Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid)","volume":"204","author":"Jhaveri","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.crad.2017.02.004_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jmri.22833","article-title":"Hepatobiliary MR imaging with gadolinium-based contrast agents","volume":"35","author":"Frydrychowicz","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00330-014-3108-y","article-title":"Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla","volume":"24","author":"Verloh","year":"2014","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.crad.2017.02.004_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1148\/radiol.13122482","article-title":"Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging","volume":"269","author":"Feier","year":"2013","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/jmri.23758","article-title":"Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio","volume":"36","author":"Goshima","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.crad.2017.02.004_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1148\/radiol.14131890","article-title":"Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study","volume":"271","author":"Bastati","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.crad.2017.02.004_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3348\/kjr.2015.16.3.523","article-title":"Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging","volume":"16","author":"Sato","year":"2015","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.crad.2017.02.004_bib16","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.ejrad.2011.08.008","article-title":"The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study","volume":"80","author":"Cho","year":"2011","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.crad.2017.02.004_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study Group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","article-title":"Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system","volume":"12","author":"Strasberg","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"2","key":"10.1016\/j.crad.2017.02.004_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jmri.22054","article-title":"Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine","volume":"31","author":"Filippone","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.crad.2017.02.004_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mri.2012.01.004","article-title":"Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging","volume":"30","author":"Higaki","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.crad.2017.02.004_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jmri.23874","article-title":"Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient","volume":"37","author":"Kim","year":"2013","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"10.1016\/j.crad.2017.02.004_bib23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00535-012-0740-7","article-title":"Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis","volume":"48","author":"Kim","year":"2013","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.crad.2017.02.004_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00330-013-3086-5","article-title":"Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function","volume":"24","author":"Yoneyama","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2017.02.004_bib25","series-title":"Applied logistic regression","author":"Hosmer","year":"2000"},{"issue":"4\u20135","key":"10.1016\/j.crad.2017.02.004_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000364836","article-title":"New perspectives in the assessment of future remnant liver","volume":"31","author":"Cieslak","year":"2014","journal-title":"Dig Surg"},{"issue":"1","key":"10.1016\/j.crad.2017.02.004_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1148\/radiol.10100621","article-title":"Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted\u00a0MR imaging\u2014preliminary observations","volume":"259","author":"Watanabe","year":"2011","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.crad.2017.02.004_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jmri.23691","article-title":"MR prediction of liver fibrosis using a liver-specific contrast agent: superparamagnetic iron oxide versus Gd-EOB-DTPA","volume":"36","author":"Nishie","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.crad.2017.02.004_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jmri.22635","article-title":"Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors","volume":"34","author":"Chernyak","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"10.1016\/j.crad.2017.02.004_bib30","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s00330-014-3291-x","article-title":"Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests","volume":"24","author":"Kukuk","year":"2014","journal-title":"Eur Radiol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926017300697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926017300697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:35:05Z","timestamp":1757867705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926017300697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0009926017300697"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2017.02.004","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can contrast-enhanced MRI with gadoxetic acid predict liver failure and other complications after major hepatic resection?","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}